carpipramine
This page covers all carpipramine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(2) dopamine receptor, D(3) dopamine receptor.
Targets
D(2) dopamine receptor, D(3) dopamine receptor
Phase 2 pipeline (1)
- Defekton · Other
Defekton works by blocking dopamine receptors in the brain, which can help regulate mood and behavior.
Patent intelligence
- carpipramine patent landscape — aggregated cliff calendar, attackable patents, originator estates